A company using AI-powered CT imaging biomarkers and clinical data platforms to advance lung and heart disease research has appointed Rebecca Simmons as COO.

Simmons will lead Qureight’s scaling of global operations and support sustainable growth as it expands the use of its technology in clinical trials.

She brings more than 20 years of operational leadership experience, most recently as COO of quantum computing firm Riverlane, where she helped scale the business and supported over £100 million in venture funding.

Her background also includes senior roles across healthcare research, academia and public sector partnerships.